| William Michael Stephenson, LPN | |
|
13802 Queens Blvd, Briarwood, NY 11435-2665 | |
| (718) 206-2000 | |
| Not Available |
| Full Name | William Michael Stephenson |
|---|---|
| Gender | Male |
| Speciality | Licensed Vocational Nurse |
| Location | 13802 Queens Blvd, Briarwood, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649862699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 318741-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Michael Stephenson, LPN 50 Warren St, Ellenville, NY 12428-2216 Ph: (845) 665-1054 | William Michael Stephenson, LPN 13802 Queens Blvd, Briarwood, NY 11435-2665 Ph: (718) 206-2000 |
News Archive
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that eventually destroys most motor neurons, causing muscle weakness and atrophy throughout the body. There is no cure and the current treatment has only a moderate effect on the march of the disease, which typically kills within three to five years. This week in PNAS, a team of Brandeis scientists reports an innovative approach to treating the most common form of familial ALS, commonly known as Lou Gehrig's disease.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
Researchers in the United States have conducted comprehensive profiling of humoral immune responses in pregnant, lactating, and non-pregnant women following coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccination to probe differences in vaccine-induced immunity.
Bioness Inc., today announced the commercial release of its NESS L300 Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300 Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.
In a moving scene, the President of The Disabled Veterans National Foundation (www.dvnf.org ) and Michael McNaughton - a combat soldier who lost his leg on a mission in Afghanistan- delivered Gift Cards to veterans who are patients in the amputee wing at Walter Reed National Military Medical Center in Bethesda, MD over the holidays.
› Verified 8 days ago
Debra Witherspoon-benders, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: Samaritan Daytop Village 138-02 Queens Boulevard, Briarwood, NY 11435 Phone: 845-647-6575 |